HRT Financial’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,251
Closed -$39K 3595
2024
Q4
$39K Buy
+11,251
New +$15.9K ﹤0.01% 2133
2024
Q3
Sell
-14,307
Closed -$12K 3304
2024
Q2
$12K Buy
+14,307
New +$13.6K ﹤0.01% 1990
2024
Q1
Sell
-27,036
Closed -$26K 3251
2023
Q4
$26K Buy
+27,036
New +$26.2K ﹤0.01% 2015
2023
Q3
Sell
-83,401
Closed -$100K 3255
2023
Q2
$100K Buy
+83,401
New +$106K ﹤0.01% 1969
2023
Q1
Sell
-62,510
Closed -$116K 3330
2022
Q4
$116K Sell
62,510
-189,823
-75% -$371K ﹤0.01% 2039
2022
Q3
$487K Sell
252,333
-187,489
-43% -$421K 0.01% 1627
2022
Q2
$914K Buy
439,822
+404,994
+1,163% +$1.3M 0.01% 1017
2022
Q1
$159K Buy
+34,828
New +$194K ﹤0.01% 2547
2021
Q4
Sell
-79,892
Closed -$494K 4250
2021
Q3
$494K Buy
+79,892
New +$549K ﹤0.01% 2002
2019
Q1
Sell
-15,759
Closed -$40K 832
2018
Q4
$40K Buy
+15,759
New +$52.8K 0.01% 540

Other funds holding CMRX

HRT Financial's CMRX Position: Q1 2025 in Review

HRT Financial sold out of Chimerix, Inc. (CMRX) in Q1 2025, closing a stake of 11,251 shares — an estimated $39K sold.

HRT Financial first reported a position in CMRX in Q4 2018 and held it in 10 quarters. The position peaked at $914K in Q2 2022. 119 funds tracked by Wall St. Rank hold CMRX as of Q1 2025.

  • HRT Financial reported no remaining Chimerix, Inc. position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 11,251 Chimerix, Inc. shares in Q1 2025, an estimated $39K.
  • HRT Financial first reported a position in Chimerix, Inc. in Q4 2018 and held it in 10 quarters.
  • HRT Financial's Chimerix, Inc. position peaked at $914K in Q2 2022.
  • 119 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.